Letosteine
![]() | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Other names | 2-[2-(ethoxycarbonylmethylsulfanyl)ethyl]-1,3-thiazolidine-4-carboxylic acid |
| ATC code | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C10H17NO4S2 |
| Molar mass | 279.378 g/mol |
| 3D model (JSmol) | |
| |
| |
| Template:Xmark | |
|
WikiDoc Resources for Letosteine |
|
Articles |
|---|
|
Most recent articles on Letosteine |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Letosteine at Clinical Trials.gov Clinical Trials on Letosteine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Letosteine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Letosteine Discussion groups on Letosteine Patient Handouts on Letosteine Directions to Hospitals Treating Letosteine Risk calculators and risk factors for Letosteine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Letosteine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Letosteine is a mucolytic patented (U.S. patent 6987120) by Piero del Soldato of Milan, Italy.[1] He filed his application in 2000.
References
- Articles with short description
- Articles with changed DrugBank identifier
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Articles without EBI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drug
- Antitussives
- Carboxylic acids
- Thioethers
- Thiazolidines
- Carboxylate esters
- Ethyl esters
